Crystal structure of sunvozertinib, C29H35ClFN7O3, from synchrotron X-ray powder data and DFT optimization

Salazar, J.K.; Kaduk, J.A.; Dosen, A.; Blanton, T.N.

doi:10.1107/S2056989026004706

Acta Crystallographica Section E
Acta Crystallographica
Section E CRYSTALLOGRAPHIC COMMUNICATIONS

IUCr IT WDC

home archive editors for authors for readers submit open access

view article

Figure 2
Comparison of the refined structure of sunvozertinib molecule B (red) to the VASP-optimized structure (blue). The comparison was generated using the Mercury Calculate/Molecule overlay tool; the r.m.s. difference is 0.636 Å.

CRYSTALLOGRAPHIC
COMMUNICATIONS

ISSN: 2056-9890

Volume 82| Part 6| June 2026| Pages 634-638

https://doi.org/10.1107/S2056989026004706

Open

access

Follow Acta Cryst. E

Search IUCr Journals		doi		Advanced search
Author		volume	page